Pregled bibliografske jedinice broj: 1120276
Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997–2002)
Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997–2002) // Journal of Antimicrobial Chemotherapy, 58 (2006), 1; 159-167 doi:10.1093/jac/dkl147 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1120276 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Hospital consumption of antibiotics in 15 European
countries: results of the ESAC Retrospective Data
Collection (1997–2002)
Autori
Vander Stichele, R. H. ; Elseviers, M. M. ; Ferech, M. ; Blot, S. ; Goossens, H.
Kolaboracija
ESAC project group
Izvornik
Journal of Antimicrobial Chemotherapy (0305-7453) 58
(2006), 1;
159-167
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Hospital ; antibiotics ; 15 European countries
Sažetak
Objectives: To collect reliable, comparable and publicly available data on hospital use of antibiotics in Europe aggregated at the national level (1997-2002). Methods: Consumption data of systemic antibiotics in Anatomical Therapeutic Chemical (ATC) class J01 were collected and expressed in defined daily doses (DDD) per 1000 inhabitants per day. Valid data for 2002 were available for 15 countries, and 6 year trends for 10 countries. Comparison with ambulatory care (AC) consumption data was possible in 14 countries. Results: In 2002, median national hospital antibiotic consumption in Europe was 2.1 DDD/1000 inhabitants/day in Europe, ranging from 3.9 in Finland and France to 1.3 in Norway and Sweden. Hospital care (HC) consumption as a proportion of total antibiotic consumption ranged from 17.8% to 6.4%. The consumption of hospital-specific antibiotics ranged from 0.43 DDD/1000 inhabitants/day in Greece and 0.08 in Sweden. Six- year trends in consumption were stable, except for rising co-amoxiclav exposure and more rapid market penetration of new antibiotics (e.g. levofloxacin) in some countries. There was a strong, positive correlation between the extent of antibiotic use in AC and in HC (Spearman coefficient 0.745 ; P = 0.002), both for overall use and for use of five main classes (not macrolides and 'others'). In contrast to AC consumption no substantial seasonal variation in consumption was observed. Conclusions: It was cumbersome but feasible to collect ecological data on hospital antibiotic consumption in a set of 15 European countries on a retrospective basis, illustrating substantial cross-national variations in the extent and distribution of exposure to antibiotics in hospital care.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Arjana Tambić-Andrašević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE